Penny Stock Rips 260% Higher On Fast Track Designation For Experimental Lung Cancer Gene Therapy

 

Penny Stock Rips 260% Higher On Fast Track Designation For Experimental Lung Cancer Gene Therapy

Genprex said it’s planning to initiate a Phase 1/2 clinical trial to evaluate Oncoprex in combination with Tagrisso as well as a new Phase 1 trial to evaluate it in combination with a checkpoint …

More Penny Stock Rips 260% Higher On Fast Track Designation For Experimental Lung Cancer Gene Therapy Videos

Leave a Reply